The striatal dopaminergic function is mediated by the inhibition of a nigral, non-dopaminergic neuronal system via a strio-nigral GABAergic pathway.
D000613:Aminobutyrates / Q000502:physiology*; D000818:Animals; D002375:Catalepsy / Q000139:chemically induced; D003342:Corpus Striatum / Q000502:physiology*; D004298:Dopamine / Q000502:physiology*; D007839:Functional Laterality; D018756:GABA Antagonists; D006801:Humans; D007555:Isoxazoles / Q000494:pharmacology; D008297:Male; D009433:Neural Inhibition; D009434:Neural Pathways / Q000502:physiology; D010852:Picrotoxin / Q000494:pharmacology; D051381:Rats; D013239:Stereotyped Behavior / Q000187:drug effects; D013378:Substantia Nigra / Q000502:physiology*; D005680:gamma-Aminobutyric Acid / Q000502:physiology*
D000613:Aminobutyrates; D004298:Dopamine; D018756:GABA Antagonists; D007555:Isoxazoles; D010852:Picrotoxin; D005680:gamma-Aminobutyric Acid